Ahmet Burak Agaoglu

7PUBLICATIONS
39CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 16, 2026
Autophagy- and Stress-Related Biomarkers in Pretreatment Rectal Adenocarcinoma Biopsies: Associations With Pathologic Response to Neoadjuvant Therapy and Survival.

|Jul 15, 2026
Real-World Outcomes and Prognostic Factors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Multicenter Study.

|Jun 11, 2026
Prognostic value of the CHAM score in non-small cell lung cancer patients treated with nivolumab.

|Nov 27, 2025
Neoadjuvant Regimens and Their Impact on Adjuvant T-DM1 Outcomes in HER2-Positive Early Breast Cancer.

Ahmet Burak Agaoglu, Atike Pinar Erdogan, Ferhat Ekinci

|Oct 29, 2025
Survival Benefit of Temozolomide Plus Irinotecan as Second-Line Therapy in Small Cell Lung Cancer: A Retrospective Single-Center Study.

Omer Acar, Ahmet Burak Agaoglu, Mustafa Sahbazlar

|Aug 02, 2025
Clinicopathological Perspectives of Liver Mass Biopsies: A Single Center Experience of 406 Cases.

Ömer Atmış, Hanife Seda Mavili, Fatma Seher Pehlivan

Pageof 2

Frequent Collaborators

5 joint publications

Atike Pınar Erdogan

5 joint publications

Ferhat Ekinci

2 joint publications

Mustafa Sahbazlar

2 joint publications

Ömer Atmış